At Yunique Medical, we transition you off semaglutide slowly and reinforce the metabolic and nutritional changes that sustain your results
Pharmacy, formulation, packaging, and availability may vary by patient and state
Originally introduced as a treatment for type 2 diabetes, Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) quickly gained widespread popularity after the FDA approved semaglutide for weight management
Users already on prescription GLP-1 shots say the added vitamins keep energy steady and hair happy while pounds drop
10.1111/dom.13761 Summary Keywords anti-inflammatory, atherosclerosis, coronary artery disease, glucagon-like peptide-1, mechanisms Citation Skrobucha A, Pindlowski P, Krajewska N, Grabowski M and Jonik S (2024) Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review
182 Although it is not clear whether there is crosstalk between diabetes and PD in neurogenesis, similar pathophysiological changes may indicate a close association between the two diseases